Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice
- 5 April 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (6) , 1940-1952
Abstract
Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the regulation of blood pressure. We hypothesized that nicotine-induced blood pressure elevation is in part mediated by change in renal 11β-HSD2 leading to higher MR (mineralocorticoid receptor) occupancy. Here, we show that nicotine exposure markedly decreased the expression and activity of renal 11β-HSD2 and increased the mean systolic arterial pressure in C57BL/6J mice. Reduction of renal 11β-HSD2 expression by nicotine was correlated with the suppression of C/EBPβ (CCAAT/enhancer-binding protein-β) and activation of Akt protein kinase phosphorylation (pThr 308 Akt/PKB) within the kidney. Conversely, nicotine-treated mice had elevated renal MR and epithelial sodium channel-α abundance. Treatment with the MR antagonist spironolactone significantly decreased the elevated mean systolic blood pressure and corrected ENaC along with inhibition of pThr 308 Akt/PKB within the kidney in nicotine-treated mice. Suppression of Akt/PKB activation by spironolactone was accompanied by upregulation of renal C/EBPβ and amelioration of nicotine-mediated reduction of 11β-HSD2. Addition of nicotine to mouse renal cortical collecting duct M1 cells downregulated 11β-HSD2 and stimulated MR expression, and these effects are likely mediated by activation of Akt coupled inhibition of C/EBPβ. These findings suggest that nicotine-mediated suppression of 11β-HSD2 in the kidney may contribute to the development of nicotine/smoking-induced hypertension through decreasing the intrarenal deactivation of glucocorticoids. Spironolactone may prove useful in protecting against the hypertensive risks of nicotine/smoking.Keywords
This publication has 63 references indexed in Scilit:
- Increased Renal Epithelial Na Channel Expression and Activity Correlate With Elevation of Blood Pressure in Spontaneously Hypertensive RatsHypertension, 2013
- Nicotine stimulates secretion of corticosterone via both CRH and AVP receptorsJournal of Neurochemistry, 2011
- Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Aldosterone activates endothelial exocytosisProceedings of the National Academy of Sciences, 2009
- Glucocorticoid-Related Signaling Effects in Vascular Smooth Muscle CellsHypertension, 2008
- DHEA Induces 11β-HSD2 by Acting on CCAAT/Enhancer-Binding ProteinsJournal of the American Society of Nephrology, 2008
- Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced HypertensionHypertension, 2001
- Effects of spironolactone on systolic blood pressure in experimental diabetic ratsKidney International, 2000
- Gene Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic RatsHypertension, 1998
- 11α- and 11β-Hydroxyprogesterone, Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase, Possess Hypertensinogenic Activity in the RatHypertension, 1996